These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Management of non-malignant results in core needle biopsy of breast lesions].
    Author: Fan ZQ, Ouyang T, Li JF, Wang TF, Xie YT, Fan T, Zhang Z, Lin BY.
    Journal: Zhonghua Yi Xue Za Zhi; 2008 Sep 09; 88(34):2387-90. PubMed ID: 19087711.
    Abstract:
    OBJECTIVE: To study the strategy of management of non-malignant results in core needle biopsy (CNB) of breast lesions. METHODS: Consecutive 2654 breast lesions underwent CNB with 14-gauge automated needles. 1130 lesions with diagnosis of non-malignant breast lesions examined by CNB were followed up. The histological diagnosis of CNB, subsequent excision or repeat CNB, and the follow-up for cases without repeat biopsy were studied. RESULTS: Among the 1130 non-malignant breast lesions examined by CNB, 530 underwent re-biopsy and 73 cases of carcinoma were found. 491 lesions were followed up for 1 - 38 months (median, 13.3 months) and another 4 cases of carcinoma were found during the follow-up. 109 cases were lost to follow-up. 57.9% (22/38) of the atypical ductal hyperplasia, 22.2% (4/18) of the atypical ductal cells, 27.9% (24/86) of the papillary lesions, and 90.0% (9/10) of the suspicious carcinoma diagnosed by CNB were re-diagnosed as breast cancer finally. CONCLUSIONS: Repeat biopsy is required for the high-risk lesions diagnosed by breast CNB. Excision can be avoided on the benign lesions whose CNB diagnosis is consistent with those by physical examination and imaging.
    [Abstract] [Full Text] [Related] [New Search]